Heart Disease
Fibromyalgia
High Cholesterol Danger?
Toxic Metals
Free Radicals -- Primer
IV Chelation Therapy

Wrong Diet Causes Diabetes

Vibrant Life Home Web
Family Of Three Oral Chelation Formulas
The Wednesday Letter
The Hubbard Human Detoxification Program
Hopeless Diseases -- Invented to Sell Drugs
Wrong Relationship Cause of Disease

Brain Chemical Imbalance
Dr. Garry F. Gordon
Ultimate Resource On Chelation Therapy Home Page

Shopping Cart

Separate Search Page
or search below


Prevent Cancer

Oral Chelation Therapy
Other

Karl Loren's Policy On Psychiatric Drugs
Destruction Of American Education
Write To Karl Loren Table Of Contents

Hemochromatosis Disease -- The Hopeless Disease

Source

Centers for Disease Control and Prevention  Centers For Disease Control

Iron Overload and Hemochromatosis

In the United States, most cases of "iron overload" are caused by a genetic condition known as "hereditary hemochromatosis." Serious and sometimes fatal health problems may result from the excess iron that accumulates in the body. These complications may include severe weakness or fatigue, unexplained joint or abdominal pain, impotence, infertility, and loss of menstrual periods. The diseases associated with hemochromatosis include liver cancer, cirrhosis, arthritis, diabetes, and heart failure.

Overview on Iron Overload and Hemochromatosis 
This section provides basic information on hemochromatosis, the signs and symptoms, diagnosis, treatment, questions regarding blood donation, prognosis and public health issues related to hemochromatosis.

Iron Overload Disease due to Hereditary Hemochromatosis
Additional background information, a diagram depicting the course of hereditary hemocromatosis, CDC program activities, and priorities for 2001 can be found here.

Screening for Iron Overload due to Hereditary Hemochromatosis
Information on identifying people early with evidence of iron overload. 

Information for Patients and Their Families
You can live a healthy life, if you get treatment early.

Frequently Asked Questions
Definitions, signs and symptoms, risk factors, detection, prevalence, treatment, blood donation, diet, causes, history, and important information regarding the CDC and Hemochromatosis.

Resources
Helpful resources can be found here.
 


Iron overload and Hemochromatosis
Overview on Iron Overload and Hemochromatosis

Hemochromatosis is a condition in which the body accumulates excess amounts of iron. Hereditary hemochromatosis is one of the most common genetic diseases in humans. In the United States, as many as one million people have evidence of hemochromatosis, and up to one in every ten people may carry the gene for the disorder. Serious and sometimes fatal health problems may result from the excess iron that accumulates in the body as a result of this genetic disorder. Some diseases associated with hemochromatosis are arthritis, cirrhosis of the liver, diabetes, heart failure, and liver cancer.

Signs and Symptoms

Symptoms associated with hemochromatosis most often appear in middle age, although some people may develop problems earlier. These symptoms reflect the tissue and organ damage that result from the disease.

  • Early disease symptoms of hemochromatosis are nonspecific and include fatigue, heart palpitations, joint pain, non-specific stomach pain, impotence, and loss of menstrual periods. Abnormalities of liver function tests can also occur in the absence of other symptoms.

     
  • Later disease symptoms include gray or bronze skin pigmentation, cirrhosis of the liver, liver cancer, diabetes mellitus, hypopituitarism, decreased pituitary or gonadal function, heart disease or heart failure, joint disease, chronic abdominal pain, severe fatigue, and certain infections.

Excess iron in the diet, alcohol use, infections, iron lost through blood donations and menstruation, and other environmental factors may affect the clinical course of hemochromatosis. For example, alcohol use may worsen the disease, whereas iron lost through blood donations or menstruation may lessen the severity.


Diagnosis

Early detection of hemochromatosis is essential because the disease's potentially serious complications can be prevented by early therapy. A sensitive and relatively inexpensive screening test for iron overload is the transferrin saturation test (serum iron divided by the total iron binding capacity). Quantitative phlebotomy is now considered the diagnostic test of choice by most health care providers.

Currently, routine medical care or checkups usually do not include testing for hemochromatosis and many cases may remain undetected.

People who have a close blood relative with hemochromatosis, as well as persons who have the signs and symptoms compatible with hemochromatosis (as described above), should talk with their health care provider about the possibility of being evaluated for hemochromatosis.



Treatment

Periodically removing blood, also called phlebotomy (fle-bot-o-me), to remove excess iron is a necessary component in treating hemochromatosis. In the initial phase of treatment, one unit of whole blood, which contains about 250 milligrams of iron, is removed, usually once or twice weekly. This "de-ironing" phase continues until all excess stored iron is removed, as indicated by monitoring hemoglobin and serum ferritin concentrations. The frequency and duration of this process can vary among patients by age, gender, reason for diagnosis, and severity of symptoms.

The second phase of treatment is long-term maintenance of normal iron stores. The frequency of blood removal in this phase is determined individually for each patient, according to symptoms and levels of hemoglobin and serum ferritin.


Questions Regarding Blood Donation

Frequently patients and their care providers ask whether it is safe for individuals with hemochromatosis to donate blood to community organizations. The Food and Drug Administration (FDA) recently announced that blood from therapeutic phlebotomies for persons with hemochromatosis could be used for transfusion if the blood donation facility met certain criteria: 1) the blood collection center may not charge for the therapeutic phlebotomy and 2) the blood center must apply to FDA for exemption from existing regulations. As part of that exemption, the blood center must collect and submit specified data to the FDA. The FDA will consider exemption applications on a case-by-case basis. Additional questions regarding blood donation from patients with hemochromatosis should be referred to the FDA at http://www.fda.gov/cber/blood.htm 1-888-889-7274.


Prognosis

The degree of organ damage from iron overload at the time of diagnosis is the major determinant of a person’s prognosis. For a person who has no evident tissue or organ damage, proper management of the disease may result in a normal long-term outcome and life expectancy. For a person who has evident tissue or organ damage, further damage can be halted, but damage already incurred may not be reversible.


Public Health Issues
Related to Hemochromatosis

The prevention and control of hemochromatosis is an achievable goal and is important to the overall prevention of chronic disease. In the United States, it is estimated that as many one in every 200 to 500 people, or approximately one million people, have evidence of hemochromatosis, and as many as one in every 10 people may carry the gene for this hereditary disease.

The research priorities include (1) determining the proportion of people with hemochromatosis who will become symptomatic and (2) evaluating the risks, benefits, and effectiveness of different methods of case detection and follow-up.

Educating health care providers and patients about hemochromatosis is central to the public health plan of action. The 1996 identification of the gene associated with hemochromatosis has provided an important opportunity to prevent the progression and symptomatic complications of hemochromatosis. It remains to be determined how best to use genetic testing to assist clinicians and patients.

For general information on hemochromatosis, you may contact the CDC’s Nutrition and Physical Activity Program. If you have any questions or comments, please contact us.


;

Iron overload and Hemochromatosis
Iron Overload Disease due to Hereditary Hemochromatosis

Background

In the United States iron overload is primarily due to a genetic disorder known as hereditary hemochromatosis. Hemochromatosis is characterized by lifelong excessive absorption of iron from the diet, with iron accumulating in body organs, eventually causing inflammation and damage. Serious and even fatal health effects can result, including cirrhosis of the liver, liver cancer, heart abnormalities (leading to heart failure), diabetes, impotence, and arthritis. Approximately one of every 200 to 400 people is affected, while one in 10 is a carrier making this one of the most common of the known genetic disorders in the United States. The availability of diagnostic tests for serum iron measures and the recent discoveries of the genetic mutations responsible for hemochromatosis provide the potential for early detection. However, the social, ethical, and legal implications of such genetic testing and screening are only beginning to be explored.

Treatment by periodic removal of iron (by blood removal, or phlebotomy) is safe and effective, and can lead to a normal life expectancy if initiated before organ damage has occurred. Early detection and treatment for this genetic condition can lessen morbidity and mortality, and in some cases prevent the onset of disease. Therefore, early detection of hemochromatosis represents a major chronic disease prevention opportunity. Hereditary hemochromatosis is often referred to as the "poster child" genetic disorder because it serves as a model for formulating policy decisions about genetic-associated diseases.

 

Chart reflecting the course of hereditary hemochromatosis.

[Text Description]
slope depends on individual

 

CDC Program Activities

  • Examine laboratory quality assurance for serum iron measures
  • Validate diagnostic tests and assess their usefulness in diagnosis and screening
  • Educate health care providers about the importance of early diagnosis and treatment
  • Educate patients about hemochromatosis and the need to test close blood relatives for this genetic condition
  • Characterize the prevalence of hemochromatosis and its associated morbidity and mortality


     

Priorities for 2002

  • Complete Web-based hemochromatosis teaching module for health care providers
  • Publish inter-laboratory comparisons for serum iron measures
  • Recommend diagnostic test cut-points
  • Expand prevalence estimates for hemochromatosis and its associated morbidity and mortality in the United States
  • Describe clinical course of illness
  • Conduct analysis of data from patient studies

 


Iron overload and Hemochromatosis
Screening for Iron Overload due to Hereditary Hemochromatosis

Michele Reyes PhD, Heidi Michels Blanck PhD, and Muin J. Khoury MD PhD

Identifying people early with evidence of iron overload represents a major chronic disease prevention opportunity. Because iron loading caused by hereditary hemochromatosis is common and can be effectively treated with periodic phlebotomy, both the medical community and patient support groups have advocated population screening. In fact, it has been suggested that hereditary hemocromatosis serve as a model for formulating policy decisions about genetic-associated diseases, in particular for decisions about the usefulness of genetic screening. However, at this time, CDC does not recommend universal screening for hereditary hemochromatosis because of many unresolved issue.1,2  Of utmost concern is the uncertainty about what proportion of people with genetic risk or biochemical evidence of iron overload will develop the complications of iron overload. Although HFE gene mutation testing can identify those relatives who carry susceptible genotypes, testing iron status directly is not only more relevant clinically than genetic testing but also avoids the possibility of adverse genetic discrimination.1  

CDC currently recommends iron overload testing for persons who have a close blood relative with hereditary hemochromatosis, because they have a substantial risk of developing clinical complications and represent an ideal group for targeted prevention efforts. In addition, persons experiencing the unexplained symptoms compatible with hemochromatosis (these symptoms include severe weakness or fatigue; unexplained joint or abdominal pain; signs of liver disease, diabetes, or heart problems; impotence; infertility; and loss of menstrual periods) should also be tested.2  Testing to exclude other causes of these medical problems should also be performed. 

Persons with elevated iron or liver function measures should be monitored by their health care provider. Strategies are needed to disseminate information to family members about their genetic risk and to aid their efforts to be tested. This challenge must be accomplished in the course of patient care. Educational efforts are needed to heighten awareness of the genetics of iron overload and prevention opportunities among family members. To this end, CDC, in collaboration with other partners, is developing a national education campaign to heighten health care providers' awareness of the need for early diagnosis and treatment of iron overload due to hereditary hemochromatosis. 


 

References

  1. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, et al. Hereditary hemochromatosis. Gene discovery and its implications for population-based screening. JAMA 1998;280(2):172—8.

     
  2. Cogswell ME, Burke W, McDonnell SM, Franks AL. Screening for hemochromatosis. A public health perspective. Am J Prev Med 1999;16(2):134—140.

     


Iron overload and Hemochromatosis
Information for Patients and Their Families

You can live a healthy life, if you get treatment early.

Iron overload

What is iron overload?

Iron overload is a serious chronic condition that develops when your body absorbs too much iron over many years.

Is iron overload dangerous?

If iron overload is treated before it can damage your organs, you can live a normal healthy life. However, if not treated early, it can become a serious health problem. The key is early diagnosis and treatment. More information on treatment.

What are the symptoms of iron overload?

Iron overload affects everyone differently. Some people feel tired. Others have heart palpitations or pain in their joints or stomach. Unfortunately, there is no definite symptom, or set of symptoms, that indicates a person has too much iron. Diagnosing iron overload can be difficult because the symptoms are like the symptoms of many other diseases.

What causes iron overload?

In the United States, iron overload is usually caused by a condition called hemochromatosis [pronounced he-mo-kro-ma-toe-sis]. Some people get iron overload because of what they eat or because of treatment for another problem, such as anemia.

Hemochromatosis
(he-mo-kro-ma-toe-sis)

What is hemochromatosis?

It's a genetic condition that usually causes the body to absorb too much iron, which—after many years—leads to iron overload.

Does everyone with hemochromatosis get iron overload?

No, but many people do. However, whether they have symptoms or not, people with hemochromatosis should have their iron levels tested regularly to make sure they stay well.

It's also important for family members to get tested to see if they have iron overload. More information on your family and hemochromatosis.

When do people with hemochromatosis begin to get sick from iron overload?

The age varies from person to person. Usually, symptoms begin during middle age. Some people get sick sooner, others later.

What happens if I don't get treatment?

If iron overload is not treated, your organs can become damaged. Eventually, iron overload could cause one or more of these conditions:

Liver cancer Diabetes Cirrhosis of the liver
Heart disease Arthritis Bronze skin
Impotence for men Infertility and loss of periods for women

Treatment for iron overload

The condition that causes iron overload cannot be cured, but it can be controlled by phlebotomy (pronounced fle-bot-o-me).

What is a phlebotomy?

It's the same procedure as when you donate blood. A nurse takes about a pint of blood from a vein in your arm. The procedure takes about an hour.

Is a phlebotomy safe?

A phlebotomy is simple, safe, and effective. However, because you'll be having frequent phlebotomies, your doctor will monitor your health more closely than if you were just donating blood.

How often must I have a phlebotomy?

Probably for about a year, you will have phlebotomies once or twice a week. How many phlebotomies you have—and how often you have them—depends on how much iron has built up in your body.

Must I have phlebotomies for the rest of my life?

Yes. However, after the iron is first lowered to a safe amount, you will have phlebotomies much less often—usually a few times a year.

Does a phlebotomy have side effects?

Everyone's experience is unique. Some people feel just fine. Others feel tired afterwards and like to rest for an hour or so. It's a good idea to drink water, milk, or fruit juices after a phlebotomy.

Without phlebotomies, iron overload can cause death.

Treatment is worth the effort.

 

Getting your iron level back to normal

Diagram of cycle of events which result from hemochromatosis

[Text Description]

What can I do to stay healthy?

There is a lot you can do to take charge of hemochromatosis and to make sure your life is as normal and healthy as possible.

Checkmark Check-ups: Have the amount of iron in your blood checked regularly.
Phlebotomy Phlebotomy: Make sure to get phlebotomies when you need them.
Food Food: Don't eat raw fish or raw shellfish. Cooking destroys germs harmful to people with iron overload.
Alcohol Alcohol: If you choose to drink alcohol, drink very little. Women should have less than one drink a day. Men should have less than two a day. However, if you have liver damage, do not drink any alcohol.
Supplements Iron pills: Don't take pills or supplements that have iron. Eating foods that contain iron is fine.
Vitamin C Vitamin C: Vitamin C increases the amount of iron your body absorbs. So, don't take pills with more than 500 mg of vitamin C per day. Eating foods with vitamin C is fine.
Excercise Exercise: You can exercise as much as you want. Indeed, it's good to exercise so you'll stay fit.

What doctors say

Prad Phatak, MD "We see so many people who find out too late that they have iron overload — after lots of damage is already done. It's vital that people with hemochromatosis urge family members to get tested immediately. Then, if they have the condition, they can get treatment before there's much damage."
  Prad Phatak, MD
  Rochester General Hospital,
  Rochester, New York


 

 

Vincent J. Felitti, MD "For a year now, we've been using blood from the phlebotomies of hemochromatosis patients for transfusions. The patients are pleased to help others in this manner, and the practice has helped greatly in a time of blood shortage."
  Vincent J. Felitti, MD
  Southern California Kaiser Permanente,
  San Diego, California


 
Michele Reyes, PhD "CDC is interested in teaching blood banks, doctors, and patients more about early diagnosis and treatment of iron overload. An important step that patients can take toward good health is to keep getting phlebotomies."
  Michele Reyes, PhD
  Centers for Disease Control and Prevention,
  Atlanta, Georgia

My family and hemochromatosis

Hemochromatosis runs in families. So, your parents, sisters, brothers, or children may also have it.

How can I help my family?

You can help by telling family members that you have hemochromatosis and that they could have it too. You can also urge them to get their iron level checked because the sooner they know whether they have iron overload, the better. People who start treatment early can stay healthy.

Why does hemochromatosis run in families?

Because hemochromatosis is caused by genes we are born with. We inherit genes from our parents, and our children inherit genes from us.

How likely are my children to have hemochromatosis?

It's impossible to answer that question because your children inherit genes not only from you, but also from their other parent. The best plan is to discuss hemochromatosis with your children's pediatrician and to have your children tested to make sure their iron levels remain normal.

Indeed, it's important for all close family members (your children, brothers, and sisters) to get their iron levels tested regularly. The earlier family members find out whether they have iron overload, the better their chances of leading a long, healthy life.

What patients are saying

Jack C. "I am one of the lucky ones—I got treatment in time. But my brother and sister were not so lucky—both died of liver disease due to iron overload. If their disease had been diagnosed earlier, they might be alive today. Please get checked if you think there's any chance you might have the disease."

 

Jack C.


 

Carol S. "I have iron overload, so I had my son tested to see if he has it too. I'm glad I did because he does have the disease, and we found out early. The doctor says if my son watches what he eats and gets phlebotomies when he needs them, he'll probably never suffer any bad effects."

Carol S.


 

Eric G. "I have hemochromatosis, and so do my daughter, Ashleigh, and my son, Adam. We take this disease very seriously and follow our treatment regimen rigorously. Early treatment is so important to saving lives, improving the quality of life, and reducing health care costs."

Eric G.

Other information

Are people with iron overload allowed to donate blood?

There is no medical reason why blood from people with iron overload should not be used for transfusions. The Food and Drug Administration has special guidelines about handling blood donations from people with iron overload.

If you are interested in donating your blood, contact your blood bank directly to find out about its policies.

How many people have iron overload?

In the United States, about one million people have iron overload due to hemochromatosis. The condition is most common among people whose ancestors came from northern Europe.

More men than women have the condition. Perhaps women are less likely to get the condition because they lose iron when they have menstrual periods or when they give birth.

Map of the U.S.

One million people in the United States have iron overload.

How to find out more

One of the best things you can do when you find out you have any type of illness is to learn as much as you can about that illness. Talk with your doctor about what to expect. Ask questions.

Sometimes it's only after you've left the doctor's office that you think of questions. After learning you have iron overload, write a list of your questions as they come to you, and then talk with your doctor again.

Remember, every question is worth asking.

For more information, check out these Internet sites:

http://www.cdc.gov/health/diseases.htm
Information on various diseases (including iron overload and hemochromatosis) from the Centers for Disease Control and Prevention.

http://www.nhgri.nih.gov/DIR/VIP
Information on genetics for physicians and nurses — National Institutes of Health.

http://gslc.genetics.utah.edu/*
Information on genetics for patients — University of Utah

You can get on the Internet free at all public libraries.

[http://www.cdc.gov/nccdphp/dnpa/00linkdesc.htm]

Remember

You can live a long, healthy life when you take charge of your iron overload.

Have the amount of iron in your blood checked regularly.
Have a phlebotomy as often as needed.
Don't eat raw fish or raw shellfish.
Stay away from alcohol.
Don't take pills with iron in them.
Don't take pills with more than 500 mg of vitamin C per day.
Follow your doctor's recommendations.

Begin treatment as soon as possible.

The earlier you get treatment, the better your chances of staying healthy.

Urge your family members to get tested.

Please get tested!


 


Iron overload and Hemochromatosis
Frequently Asked Questions

Definitions

What is iron overload?

Iron overload is a condition in which the body absorbs and accumulates too much iron.

Humans extract needed iron, via the intestine, from the diet. When there are adequate iron stores, intestinal absorption of iron is reduced to avoid excessive accumulation of iron. When the regulation of intestinal iron absorption is altered, the body can absorb too much iron leading to iron overload. Multiple conditions can cause iron overload including transfusion-related and dietary iron overload. The most common form of iron overload in the United States is an inherited condition called hereditary hemochromatosis.

What is hereditary hemochromatosis?

Hereditary hemochromatosis is a genetic disease that is the result of inheriting two defective copies of a particular gene, one from each parent. The mutation in this gene causes the intestine to absorb too much iron. Over time, usually several years, this excess iron is deposited in the cells of the liver, heart, pancreas, joints, and pituitary gland. If left untreated, organ damage can result.


 

Signs and Symptoms

What are the signs and symptoms of hemochromatosis?

In the early stages of hemochromatosis, symptoms are non-specific and mimic a variety of other disease symptoms. Symptoms can include fatigue, palpitations, joint pain, non-specific stomach pain, and impotence, as well as loss of menstruation and infertility. Abnormalities of liver function tests can also occur in the absence of symptoms. The consequences of advanced hemochromatosis include gray or bronze skin pigmentation, cirrhosis of the liver, liver cancer, diabetes, heart disease, joint disease, chronic abdominal pain, severe fatigue and certain infections. Death may result from cardiac arrhythmia, congestive heart failure, diabetes, liver failure, and liver cancer.

What kind of health complications can the disease cause?

The later consequences include skin pigmentation, cirrhosis of the liver, liver cancer, diabetes mellitus, heart disease, joint disease, severe fatigue, and chronic abdominal pain.

Are there certain conditions that only hemochromatosis victims suffer?

The bronzing pigmentation associated with the later stage of hemochromatosis is the only unique sign of the disorder but not every affected individual develops this complication. Unfortunately, there is no sign or symptom or constellation of signs and symptoms specific for hemochromatosis. Because hemochromatosis symptoms mimic a variety of other diseases, the diagnosis of hemochromatosis can be missed unless specific tests (serum iron measures) are conducted.


 

Risk

Who is most at risk for the disorder?

Siblings of persons with the disorder have a 25% chance of carrying the mutations responsible for hereditary hemochromatosis, while children with one affected parent have a 5% chance of being affected. When both parents have the disorder, children have a 100% chance of carrying the hereditary hemochromatosis mutations. However, it is not known what proportion of these affected individuals will develop iron overload during their lifetimes. Persons who have the signs and symptoms compatible with hemochromatosis (such as severe weakness or fatigue, unexplained joint or abdominal pain, signs of liver disease, diabetes or heart problems, or elevated iron measures, impotence, infertility or loss of menstrual periods) may be at risk. These individuals should talk with their health care provider about the possibility of being evaluated for hemochromatosis.

At what ages do people experience the symptoms/complications of hemochromatosis?

The symptoms/complications of hemochromatosis typically occur in middle-age, but can occur earlier in some people. The disease progression appears to vary in each individual. It is possible that a substantial proportion of people with hemochromatosis remain healthy without treatment for many years, while a smaller proportion of people progress more rapidly through the course of their disease and they develop life-threatening complications early. Therefore, further studies are necessary to gain an understanding of the clinical course of hemochromatosis among different individuals and to gain a better understanding of factors that modify disease progression.


 

Detection

How is hemochromatosis detected?

Short answer:

A simple blood test is used to diagnose people with iron overload. The test typically used for this purpose is transferrin saturation. If the initial test comes back elevated (>45%), then a repeat test is conducted after an overnight fast. If both tests are elevated, further tests are conducted to determine if iron overload is present. For more details, refer to the recommendations in the Annals of Internal Medicine Supplement, 1 December 1998, page 955.

Unfortunately, standard cut-off points for these tests have not yet been determined. Although there is no agreement as to the standard transferrin cut-off value, most investigators suggest a value over 60% be considered abnormal, and values between 45% and 60% indicate iron overload is possible. Serum ferritin values > 200 ug/L in premenopausal females and >300 ug/L in males and post menopausal females are considered abnormal. Since serum ferritin can be elevated for reasons independent of iron overload, this measurement alone does not necessarily reflect iron overload. Both tests should be conducted to diagnose hemochromatosis.

Long answer:

High transferrin saturation is the earliest manifestation of hereditary hemochromatosis. It is recommended that people with the symptoms compatible with hereditary hemochromatosis be tested. However, not all persons with high transferrin saturation values have the disorder. To assess the presence of iron overload, serum ferritin is also measured. If this is also elevated, iron overload is likely. Confirmation of iron overload is measured directly through liver biopsy to measure the amount of iron per gram of liver tissue, or through quantitative phlebotomy, the sequential removal of 1-2 units of blood per week until a low normal serum ferritin is achieved. Iron overload is considered to be present if this procedure results in the removal of 5 gms. (or 20 units) in males or 3 gms. (or 12 units) in females before reaching low levels of serum ferritin.

(For more details, refer to the 1 December 1998 Annals of Internal Medicine supplement).

Note: Transferrin is a protein that transports iron in the blood. Individuals with high transferrin saturation values may or may not have iron overload.

Transferrrin saturation = [serum iron / total iron binding capacity (TIBC)] X 100

Is CDC telling people to go out and get tested?

At this time, CDC recommends that testing be conducted if an individual has a close blood relative with hemochromatosis or if an individual experiences the signs or unexplained symptoms compatible with hemochromatosis (such as severe weakness or fatigue, unexplained joint or abdominal pain, signs of liver disease, diabetes or heart problems, impotence, infertility and loss of menstrual periods). Testing to exclude other causes for these medical problems should be performed. People with elevated iron measures or liver function tests should be followed by their health care provider.


 

Prevalence

How many people have hemochromatosis?

It is estimated that 1 in every 200 – 500 people in the United States has hereditary hemochromatosis…about 1 million people. Whites of northern European descent are at highest likelihood of being affected, and men are more commonly affected than women, who may be protected by iron loss through menstruation and pregnancy.


 

Treatment

How do you treat hemochromatosis?

Hemochromatosis is one of the few genetic diseases for which a simple effective therapy exits. Hemochromatosis is treated by removing blood (phlebotomy) from the patient in order to lower the level of iron. There is an initial de-ironing phase, during which patients have frequent phlebotomy to remove the accumulated iron. The frequency and duration of this process varies among individual patients, but typically consists of the removal of 1-2 units of blood per week and this treatment is continued until iron concentrations come within normal limits. After this period, additional phlebotomy is performed on an "as needed basis" to keep iron levels within normal limits. When phlebotomy is begun early in the course of the illness, it can prevent most late symptoms and complications. Even when started after complications have occurred, phlebotomy can decrease symptoms and improve life expectancy.


 

Blood Donation

Is it safe for people with hemochromatosis to donate blood?

The Food and Drug Administration (FDA) recently announced that blood from therapeutic phlebotomies for persons with iron overload could be used for transfusion if certain criteria are met: 1) the blood collection center may not charge for the therapeutic phlebotomy and 2) the blood center must apply to FDA for exemption from existing regulations. As part of that exemption, the blood center must collect and submit specified data to the FDA. The FDA will consider exemption applications on a case-by-case basis.

Additional questions should be referred to the FDA.


 

Diet

Should a hemochromatosis patient avoid iron fortified food?

Hemochromatosis patients do not need to avoid iron containing foods. It is strongly recommended that hemochromatosis patients NOT take vitamin-mineral dietary supplements that contain iron. Similarly, no more than 500mg of vitamin C should be consumed because Vitamin C increases iron uptake. Such patients should avoid anything else that has the potential to cause liver damage, such as alcohol consumption—more than mild alcohol consumption should be avoided. In addition, since iron overload patients are susceptible to infections, particularly with Vibrio vullificus and Salmonella enteriditis, they must also avoid the consumption of raw shellfish and raw seafood which can contain these bacteria.


 

Causes

What causes hereditary hemochromatosis?

Hereditary hemochromatosis is an inherited condition. It occurs when a person inherits two copies of a mutation, one from each parent. People with one copy of this mutation are carriers for the condition and usually have little or no excess accumulation of iron. It is estimated that 10% of the population are carriers for hemochromatosis. However, not all people with two genetic mutations develop signs and symptoms of the disorder during their lifetimes.

Are there other disorders that cause iron overload?

In the United States, the most frequent cause of iron overload is hereditary hemochromatosis. However, there are rare genetic disorders that also result in iron overload such as neonatal hemochromatosis and juvenile hemochromatosis. In addition, iron overload can result from years of excess iron ingestion and repeated blood transfusions.


 

 


History

Although hemochromatosis was first described in the medical literature more than 100 years ago, the cause of the disease — iron accumulation, leading to damage of healthy tissues, was not initially known, and the disease was recognized only in its late stages. Over the past 15 years, studies have shown that people with early evidence of iron accumulation can be identified through blood tests (serum iron measures such as transferrin saturation and serum ferritin).

In 1996, the gene associated with hereditary hemochromatosis, HFE, was identified. Several HFE mutations have been described, but the C282Y gene mutation accounts for the majority of cases of hereditary hemochromatosis. Additional mutations have also been more recently identified. Both serum iron measures and genetic testing are imperfect screening tools because each may miss affected people and also identify people who are likely to remain well without treatment. In addition, the early symptoms and signs of iron overload are non-specific; as a result, diagnosis can be difficult. At this time, one of CDC's top priorities is health-care provider education, to heighten awareness and aid health-care providers to recognize and treat this disorder.


 

CDC and Hemochromatosis

Background

CDC sponsored a 3-day meeting of experts to discuss the many complex issues surrounding hemochromatosis. The summary of this meeting was published in the December 1998 Annals of Internal Medicine. The work of understanding the molecular genetics of hemochromatosis is underway, but many unresolved issues still remain. Most importantly, we do not yet have a clear understanding of how the disease progresses in people who test positive by either serum iron measures or a test for hemochromatosis mutations. Some people with positive tests are likely to remain healthy without treatment; for them, screening could lead to unnecessary treatment and also to the potential for discrimination on the basis of a genetic diagnosis. We are carefully reviewing the many issues related to screening, diagnosis, and treatment of hemochromatosis before we make any recommendations on a population basis.

Current

Currently, CDC does not recommend universal screening for hemochromatosis for the following reasons:

1. Uncertainty about disease progression

To date, there are not sufficient data to determine what proportion of people identified with hemochromatosis through genetic testing, or iron-overload through transferrin saturation testing will develop the complications of iron-overload. Without this information, it is not possible to determine the benefits of screening versus the potential risks resulting from unnecessary treatment.

2. Laboratory issues for diagnosis

Different laboratory methods are available for measuring transferrin saturation and serum ferritin. Variation in results from different laboratories has been observed. In addition, there is no universally accepted cut-off point indicating iron-overload. Universal screening will require a standardized, reliable method for these laboratory measurements. CDC is conducting a study to compare analytic methods for measuring iron overload among national and international laboratories, as the first step in improving diagnostic approaches. The sensitivity and specificity of these tests are not yet known. Similar issues must also be addressed for genetic testing.

3. Potential for harm from hereditary hemochromatosis diagnosis

People diagnosed with hemochromatosis may face difficulties in acquiring health, life, or disability insurance, or they may face discrimination based on having a genetic condition. Personal and family distress may occur. The ethical, legal, and social implications of this genetic testing need to be understood. In addition, current blood safety policy makes it difficult for individuals with hemochromatosis to donate blood. These potential harms indicate the need for strong evidence of benefit before universal screening is undertaken.

4. Impact of screening on the health care system

The impact of screening on primary care practices has not been evaluated. The cost effectiveness of screening needs to be determined. The costs of screening are not routinely covered by medical insurance.

5. Need to insure follow-up care of patients

If screening is recommended, efficient tracking of individuals testing positive must be developed to assure that appropriate and continuing follow-up care is provided and patient confidentiality is preserved.


Iron overload and Hemochromatosis
Resources

Links

Office of Genetics and Disease Prevention (OGDP) Hereditary Hemochromatosis: A Public Health Perspective
http://www.cdc.gov/genomics/info/perspectives/hemo.htm

National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)
http://www.niddk.nih.gov/health/digest/pubs/hemochrom/hemochromatosis.htm

Iron Disorders Institute*
http://www.irondisorders.org/

American Hemochromatosis Society, Inc.*
http://www.americanhs.org/about1.htm

University of Utah Genetic Science Learning Center—Basic Genetics Information*
http://gslc.genetics.utah.edu/basic/


 

Recent Publications

Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, et al. Hereditary hemochromatosis. Gene discovery and its implications for population-based screening. JAMA 1998;280(2):172–8.

Cogswell ME, Burke W, McDonnell SM, Franks AL. Screening for hemochromatosis. A public health perspective. Am J Prev Med 1999;16(2):134-140.

BIOIRON Conference, August, 20001, Cairns, Australia: An introduction and the abstracts from the World Congress on Iron Metabolism are available in the Journal of Clinical Gastroenterology, March 2002. Vol 34.


 



Special Pages On The Various of 19 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee High Cholesterol Risk?
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Immune Egg Central Page For All 19 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:24 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.